Shanghai Pharmaceuticals Holding Co., Ltd (HKG:2607)

HKG:2607 Ratios and Metrics

Market cap in millions HKD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jan 20, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	65,178	73,849	61,812	67,912	60,487	56,403
Market Cap Growth	-14.14%	19.47%	-8.98%	12.28%	7.24%	5.52%
Enterprise Value	96,775	101,687	88,205	91,655	94,149	84,943
Last Close Price	11.85	12.16	10.50	11.40	12.47	11.11
PE Ratio	10.56	15.24	14.89	10.69	9.68	10.56
PS Ratio	0.21	0.25	0.22	0.26	0.23	0.25
PB Ratio	0.67	0.83	0.70	0.77	0.83	0.87
P/TBV Ratio	1.10	1.26	1.10	1.21	1.54	1.65
P/FCF Ratio	18.54	20.25	24.82	29.18	52.28	12.39
P/OCF Ratio	11.06	11.91	10.73	12.67	9.74	6.94
EV/Sales Ratio	0.31	0.35	0.31	0.35	0.36	0.37
EV/EBITDA Ratio	8.48	9.30	7.94	8.37	8.55	8.15
EV/EBIT Ratio	10.90	10.92	9.33	9.93	10.27	9.82
EV/FCF Ratio	27.53	27.89	35.41	39.39	81.38	18.65
Debt / Equity Ratio	0.66	0.65	0.65	0.57	0.69	0.67
Debt / EBITDA Ratio	5.79	4.97	4.82	4.29	4.24	3.90
Debt / FCF Ratio	18.32	15.95	22.96	21.67	43.25	9.58
Asset Turnover	1.22	1.27	1.27	1.28	1.38	1.34
Inventory Turnover	6.33	6.48	6.45	6.55	7.32	6.77
Quick Ratio	1.00	1.02	0.98	0.99	0.93	0.90
Current Ratio	1.32	1.36	1.33	1.35	1.27	1.22
Return on Equity (ROE)	7.91%	7.16%	6.53%	10.20%	11.03%	10.77%
Return on Assets (ROA)	2.15%	2.52%	2.61%	2.82%	2.99%	3.18%
Return on Invested Capital (ROIC)	5.42%	6.90%	7.09%	7.95%	7.85%	8.43%
Return on Capital Employed (ROCE)	8.10%	9.20%	9.60%	9.30%	10.40%	11.90%
Earnings Yield	9.47%	6.56%	6.72%	9.35%	10.34%	9.47%
FCF Yield	5.39%	4.94%	4.03%	3.43%	1.91%	8.07%
Dividend Yield	3.77%	3.24%	4.30%	6.05%	4.13%	5.13%
Payout Ratio	50.60%	79.16%	105.66%	55.08%	52.54%	53.79%
Buyback Yield / Dilution	0.93%	-0.07%	-6.28%	-22.54%	-	-
Total Shareholder Return	4.70%	3.16%	-1.97%	-16.49%	4.13%	5.13%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.